SARILUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS OF A PHASE 2, RANDOMIZED. DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY (ALIGN)

被引：1
|
作者：
Sieper, J. [1 ]
Inman, R. D. [2 ]
Badalamenti, S. [3 ]
Radin, A. [4 ]
Braun, J. [5 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Toronto Hosp Western Div, Toronto, ON, Canada
[3] Sanofi, Clin Res, Bridgewater, MA USA
[4] Regeneron Pharmaceut Inc, Translat Med, Tarrytown, NY USA
[5] Rheumazentrum Ruhrgebiet, Herne, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.1852
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：111 / 112
页数：2
相关论文
共 50 条
  • [1] Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
    Sieper, Joachim
    Braun, Juergen
    Kay, Jonathan
    Badalamenti, Salvatore
    Radin, Allen R.
    Jiao, Lixia
    Fiore, Stefano
    Momtahen, Tanya
    Yancopoulos, George D.
    Stahl, Neil
    Inman, Robert D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1051 - 1057
  • [2] Etanercept in the treatment of ankylosing spondylitis: A randomized, double-blind, placebo-controlled study.
    Gorman, JD
    Sack, KE
    Davis, JC
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S403 - S403
  • [3] SARILUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY
    Huizinga, T. W.
    Kivitz, A. J.
    Rell-Bakalarska, M.
    Fleischmann, R. M.
    Jasson, M.
    Radin, A. R.
    Genovese, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 60 - 60
  • [4] Sarilumab for the Treatment of Moderate-to-Severe Rheumatoid Arthritis: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, International Study
    Genovese, Mark C.
    Kivitz, Alan J.
    Simon Campos, J. Abraham
    Rell-Bakalarska, Maria
    Fleischmann, Roy M.
    Jasson, Martine
    Radin, Allen R.
    Huang, Xiaohong
    Huizinga, Tom W. J.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4041 - 4042
  • [5] Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
    Deodhar, Atul
    Sliwinska-Stanczyk, Paula
    Xu, Huji
    Baraliakos, Xenofon
    Gensler, Lianne S.
    Fleishaker, Dona
    Wang, Lisy
    Wu, Joseph
    Menon, Sujatha
    Wang, Cunshan
    Dina, Oluwaseyi
    Fallon, Lara
    Kanik, Keith S.
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) : 1004 - 1013
  • [6] A randomized, double-blind, placebo-controlled trial of (Enbrel®) in the treatment of Ankylosing Spondylitis.
    Gorman, JD
    Sack, KE
    Davis, JC
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S90 - S90
  • [7] TOCILIZUMAB (TCZ) IS NOT EFFECTIVE FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS (AS): RESULTS OF A PHASE 2, INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Sieper, J.
    Porter-Brown, B.
    Thompson, L.
    Harari, O.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 110 - 111
  • [8] Efficacy of etanercept (Enbrel®) in the treatment of ankylosing spondylitis:: A randomized, placebo-controlled, double-blind study.
    Gorman, JD
    Sack, KE
    Davis, JC
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2947 - 2947
  • [9] Double-blind, randomised, placebo-controlled study of leflunomide in the treatment of active ankylosing spondylitis
    Van Denderen, JC
    Van der Paardt, M
    Nurmohamed, MT
    De Ryck, YM
    Dijkmans, BAC
    Van der Horst-Bruinsma, IE
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 397 - 397
  • [10] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
12345